ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,417Medicare Part D Prescriptions Filled, Including Refills

Rank: 258 out of 972

$501K Total Retail Price of All Prescriptions

Rank: 316 out of 972

569 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 569 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 569 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 9,512 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 521 484 1 2
LEVOTHYROXINE SODIUM 388 332 2 3
OMEPRAZOLE 377 340 3 5
AMLODIPINE BESYLATE 308 285 4 4
LISINOPRIL 301 286 5 1
FUROSEMIDE 298 286 6 7
TRAZODONE HCL 242 221 7 35
ATENOLOL 227 225 8 18
ATORVASTATIN CALCIUM 215 206 9 11
METFORMIN HCL 191 164 10 8
POTASSIUM CHLORIDE 188 182 11 13
TRIAMTERENE-HCTZ 188 176 11 39
CITALOPRAM HBR 186 176 13 19
ZOLPIDEM TARTRATE 178 166 14 23
MIRTAZAPINE 168 168 15 46
METOPROLOL SUCCINATE 166 151 16 16
METOPROLOL TARTRATE 158 158 17 9
ALLOPURINOL 154 154 18 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 153 137 19 32
FLUTICASONE PROPIONATE 151 133 20 31
TAMSULOSIN HCL 136 134 21 29
LOSARTAN POTASSIUM 135 130 22 17
TRAMADOL HCL 132 126 23 15
HYDROCODONE-ACETAMINOPHEN 130 128 S3 24 6
PRAVASTATIN SODIUM 116 97 25 20
GABAPENTIN 112 107 26 14
CYCLOBENZAPRINE HCL 110 63 R 27 53
PANTOPRAZOLE SODIUM 106 105 28 41
DONEPEZIL HCL 105 105 29 26
DIOVAN 90 78 30 48
FLUOXETINE HCL 85 65 31 60
PREDNISONE 85 84 31 40
KLOR-CON M20 84 82 33 78
HYDROCHLOROTHIAZIDE 83 72 34 10
LOSARTAN-HYDROCHLOROTHIAZIDE 82 68 35 61
ALENDRONATE SODIUM 82 80 35 27
WARFARIN SODIUM 79 67 37 12
DIGOXIN 75 74 38 52
LANTUS 72 52 39 44
SERTRALINE HCL 68 68 40 25
ISOSORBIDE MONONITRATE ER 66 66 41 43
TRIAMTERENE-HYDROCHLOROTHIAZID 66 62 41 152
LIPITOR 64 56 43 90
DILTIAZEM 24HR CD 63 63 44 74
NAMENDA 60 60 45 38
ENALAPRIL MALEATE 60 54 45 50
QUINAPRIL HCL 57 57 47 95
PROPRANOLOL HCL 53 53 48 118
ESCITALOPRAM OXALATE 53 45 48 65
NAPROXEN 51 46 50 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.